← Dissociatives

DXM

Dextromethorphan

A cough suppressant with very different effects outside its medical use.

C₁₈H₂₅NOView molecular structure

DXM is an ingredient in some cough medicines. At higher exposures it can produce dissociation, altered perception and substantial impairment.

The medicine label and the dissociative experience describe different contexts. Common availability does not make nonmedical use predictable.

DXM at a glance

Family
Morphinans
Type
Cough suppressant; dissociative
Primary target
NMDA blockade, chiefly via dextrorphan
Onset (oral)
Varies with formulation
Duration (oral)
Several hours; sometimes longer
Origin
Synthetic

What is DXM?

The body converts DXM into dextrorphan, which blocks NMDA receptors. DXM also affects other systems, including serotonin signalling and sigma-1 receptors.

The enzyme CYP2D6 influences how it is processed. Genetic differences and medicines that affect this enzyme can change the balance of effects and their duration.

The DXM experience

Sensory effects

Accounts describe altered visual perception and dreamlike imagery. At stronger intensity, confusion and reduced contact with surroundings can dominate.

Sound may feel distorted or unusually distant. Music can become central to an account, but auditory changes are variable rather than predictable.

Body sensations

Distance from the body and altered movement are common report themes. Coordination and speech may be impaired, and nausea or uncomfortable sensations can occur.

Headspace

Thoughts may feel dreamlike, disconnected or difficult to follow. Accounts range from absorption to agitation and confusion. Informal online plateaus do not reliably predict an individual experience.

Self, time and space

Time, location and bodily identity may become unfamiliar during dissociation. The character and duration of these changes vary with metabolism, formulation and other circumstances.

History and culture

DXM entered cough medicines in the twentieth century. Its dissociative use later developed a substantial online culture, including detailed experience reports.

That culture helped make an unfamiliar effect accessible to readers, but it also encouraged simplified categories that can obscure individual differences and product ingredients.

Research and uses

DXM has established use as a cough suppressant. Specific prescription combinations also use its pharmacology for other conditions, including some neurological symptoms and depression.

Those products combine controlled formulations with medical assessment. Their evidence does not establish a benefit from using cough medicines to seek dissociation.

Risks and considerations

Serotonin toxicity is a serious interaction concern, especially with MAO inhibitors and other serotonergic drugs. Severe confusion, overheating, seizures and other medical emergencies can occur.

Cough products may contain additional ingredients, such as paracetamol, antihistamines or decongestants, with their own toxicity. A product containing DXM is not necessarily DXM alone.

FAQ

Is DXM the same as an opioid painkiller?

No. Its structure is related to morphinans, but its usual pharmacology differs from opioid pain medicines.

Do all cough medicines contain only DXM?

No. Many are combination products with additional active ingredients.

Why can effects vary so much?

Metabolism, formulation, interactions and individual biology all affect the response.

Sources
  1. Dextromethorphan: clinical pharmacology
  2. Dextromethorphan toxicity
  3. PubChem: DXM molecular identity